This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Opioid Use Disorder or Opioid-related Disorders
and you are
between 18 and 65
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Study is to provide ongoing treatment with RBP-6000 and safety monitoring for subjects who complete the RB-US-13-0003 study and for whom a new treatment venue has not been identified.

Provided treatments

  • Drug: Low dose RBP-6000
  • Drug: High dose RBP-6000
Tris trial is registered with FDA with number: NCT02896296. The sponsor of the trial is Indivior Inc. and it is looking for 208 volunteers for the current phase.
Official trial title:
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder